Longwall Ventures

Investment thesis

Deep tech and hard-science specialist with 18+ years commercialising scientific research into global businesses, backing hardware, deeptech and hard-science companies that do not fit standard tech VC timelines. Notable for its stake in Oxford spinout OrganOx (19.2x return on Terumo's $1.5bn+ acquisition). Fund 4 received a GBP 50m cornerstone from the British Business Bank.

Notable portfolio

Sector focus